Oric Pharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ORIC, updated each market day.
ORIC AI Sentiment
AI predicts Oric Pharmaceuticals, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Oric Pharmaceuticals, Inc. Common Stock
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Sector
Exchange
Market Cap
$1,162,636,614
Cap Tier
Employees
104
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
April 24, 2020
Website
ORIC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ORIC Volatility
Oric Pharmaceuticals, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
